Schizophrenia and Schizoaffective Disorder
7
0
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
A Pilot Trial of Group Cognitive Behavioral Therapy for Psychosis (the Feeling Safe Programme)
Effects of RAS in SZ
Survey on the Reproductive and Child-Rearing Situations of Patients With Severe Mental Disorders
Relationship Between Physical Fitness and Psychopathology, Cognition and Quality of Life in Patients Diagnosed With Schizophrenia: a Mixed Method Study.
D-Serine Treatment For Tardive Dyskinesia
A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
Switch Study of Existing Atypical Antipsychotics to Bifeprunox